Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $30

Benzinga Newsdesk www.benzinga.com Negative 94.9%

Neg 94.9% Neu 0% Pos 0%

Oppenheimer analyst Jeff Jones maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $32 to $30.